Alcoholic hepatitis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Alcoholic hepatitis}}
{{Alcoholic hepatitis}}
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
{{CMG}}; '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]]


{{CMG}} '''Assosciate Editor(s)-In-Chief:''' [[User: Prashanthsaddala|Prashanth Saddala M.B.B.S]]
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
==Overview==
==Medical Therapy==
==Medical Therapy==
====Corticosteroids====
===Corticosteroids===
[[Clinical practice guidelines]] by the [[American College of Gastroenterology]] recommend corticosteroids.<ref name="pmid9820369">{{cite journal |author=McCullough AJ, O'Connor JF |title=Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology |journal=Am. J. Gastroenterol. |volume=93 |issue=11 |pages=2022-36 |year=1998 |pmid=9820369 |doi=}}</ref>
[[Clinical practice guidelines]] by the [[American College of Gastroenterology]] recommend corticosteroids.<ref name="pmid9820369">{{cite journal |author=McCullough AJ, O'Connor JF |title=Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology |journal=Am. J. Gastroenterol. |volume=93 |issue=11 |pages=2022-36 |year=1998 |pmid=9820369 |doi=}}</ref>


Patients with a [[discriminant function]] score > 32 or [[hepatic encephalopathy]] should be considered for treatment with [[prednisolone]] 40 mg daily for four weeks followed by a taper.<ref name="pmid9820369"/>
Patients with a [[discriminant function]] score > 32 or [[hepatic encephalopathy]] should be considered for treatment with [[prednisolone]] 40 mg daily for four weeks followed by a taper.<ref name="pmid9820369"/>
====Pentoxifylline====
===Pentoxifylline===
A randomized controlled trial found that 5 patients with a [[discriminant function]] score > 32 and at least one of palpable tender hepatomegaly, fever, leukocytosis, hepatic encephalopathy, or hepatic systolic          bruit [[number needed to treat| must be treated]] with [[pentoxifylline]] 400 mg orally 3 times daily for 4 weeks for one to prevent one patient from dying. <ref name="pmid11113085">{{cite journal |author=Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O |title=Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial |journal=Gastroenterology |volume=119 |issue=6 |pages=1637-48 |year=2000 |pmid=11113085 |doi=10.1053/gast.2000.20189 }} ([http://www.acpjc.org/Content/135/1/ISSUE/ACPJC-2001-135-1-004.htm ACP Journal Club synopsis])</ref>
A randomized controlled trial found that 5 patients with a [[discriminant function]] score > 32 and at least one of palpable tender hepatomegaly, fever, leukocytosis, hepatic encephalopathy, or hepatic systolic          bruit [[number needed to treat| must be treated]] with [[pentoxifylline]] 400 mg orally 3 times daily for 4 weeks for one to prevent one patient from dying. <ref name="pmid11113085">{{cite journal |author=Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O |title=Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial |journal=Gastroenterology |volume=119 |issue=6 |pages=1637-48 |year=2000 |pmid=11113085 |doi=10.1053/gast.2000.20189 }} ([http://www.acpjc.org/Content/135/1/ISSUE/ACPJC-2001-135-1-004.htm ACP Journal Club synopsis])</ref>
==== Acute Pharmacotherapies ====
=== Acute Pharmacotherapies ===
* In very severe disease, such as those with encephalopathy or other markers of advanced disease, treatment with steroids may improved outcome – Prednisolone 40 mg every day for 4 weeks and then tapered.
* In very severe disease, such as those with encephalopathy or other markers of advanced disease, treatment with steroids may improved outcome – Prednisolone 40 mg every day for 4 weeks and then tapered.
*:* Possible contraindications to steroids must be considered, such as acute infection, gastrointestinal (GI) hemorrhage, etc.
*:* Possible contraindications to steroids must be considered, such as acute infection, gastrointestinal (GI) hemorrhage, etc.
Line 20: Line 19:
* Propylthiouracil (PTU) has been tried in these patients and may be moderately effective in patients who continue the treatment and discontinue alcohol.
* Propylthiouracil (PTU) has been tried in these patients and may be moderately effective in patients who continue the treatment and discontinue alcohol.
* Colchicine 0.6 mg by mouth, twice daily may help to slow progression of liver disease, though the data is not conclusive.
* Colchicine 0.6 mg by mouth, twice daily may help to slow progression of liver disease, though the data is not conclusive.
==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Needs content]]
[[Category:Needs overview]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Emergency medicine]]
[[Category:Intensive care medicine]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 19:06, 1 February 2013

Alcoholic hepatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Alcoholic hepatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alcoholic hepatitis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alcoholic hepatitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alcoholic hepatitis medical therapy

CDC on Alcoholic hepatitis medical therapy

Alcoholic hepatitis medical therapy in the news

Blogs on Alcoholic hepatitis medical therapy

Directions to Hospitals Treating Alcoholic hepatitis

Risk calculators and risk factors for Alcoholic hepatitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Medical Therapy

Corticosteroids

Clinical practice guidelines by the American College of Gastroenterology recommend corticosteroids.[1]

Patients with a discriminant function score > 32 or hepatic encephalopathy should be considered for treatment with prednisolone 40 mg daily for four weeks followed by a taper.[1]

Pentoxifylline

A randomized controlled trial found that 5 patients with a discriminant function score > 32 and at least one of palpable tender hepatomegaly, fever, leukocytosis, hepatic encephalopathy, or hepatic systolic bruit must be treated with pentoxifylline 400 mg orally 3 times daily for 4 weeks for one to prevent one patient from dying. [2]

Acute Pharmacotherapies

  • In very severe disease, such as those with encephalopathy or other markers of advanced disease, treatment with steroids may improved outcome – Prednisolone 40 mg every day for 4 weeks and then tapered.
    • Possible contraindications to steroids must be considered, such as acute infection, gastrointestinal (GI) hemorrhage, etc.
  • Other considerations:
    • Acetaminophen use should be < 2gm / day
    • Fasting also increases risks of acetaminophen toxicity in alcoholics
  • Propylthiouracil (PTU) has been tried in these patients and may be moderately effective in patients who continue the treatment and discontinue alcohol.
  • Colchicine 0.6 mg by mouth, twice daily may help to slow progression of liver disease, though the data is not conclusive.

References

  1. 1.0 1.1 McCullough AJ, O'Connor JF (1998). "Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology". Am. J. Gastroenterol. 93 (11): 2022–36. PMID 9820369.
  2. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O (2000). "Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial". Gastroenterology. 119 (6): 1637–48. doi:10.1053/gast.2000.20189. PMID 11113085. (ACP Journal Club synopsis)

Template:WikiDoc Sources